Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Nov 17;18(3):396–405. doi: 10.1016/j.bbmt.2011.11.013

Figure 2. CDDO-Me administration causes a myeloid expansion in the spleen and bone marrow.

Figure 2

C57BL/6 mice were treated for 7 days with vehicle control (VC) or CDDO-Me, or 5 days with G-CSF after which mice were sacrificed and spleens and bone marrow were harvested. Single cell suspensions were stained with anti-CD11b and anti-Gr-1. A, Representative flow cytometry panels showing percentages of cells in either organ. B and C, total CD11b+Gr-1+ cell numbers in the spleen and bone marrow were enumerated. P values were determined by Dunnett’s multiple comparison test.